|Articles|February 1, 2017
- BioPharm International-02-01-2017
- Volume 30
- Issue 2
BioPharm International, February 2017 Issue (PDF)
Click the title above to open the BioPharm International February 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
mAb Purification: Rethinking the Initial Capture Stepabout 9 years ago
Ensuring the Biological Integrity of Raw Materialsabout 9 years ago
Pumping Fluids in Biopharmaceutical Processingabout 9 years ago
Preventive Maintenance of Single-Use Tubing for Peristaltic Pumpsabout 9 years ago
Mass Spectrometry Measures Up to Analytical Challengesabout 9 years ago
Regulatory Reform Is Not That Simpleabout 9 years ago
Evaluating E&L Studies for Single-Use Systemsabout 9 years ago
Ensuring Sterility in Small-Scale Productionabout 9 years ago
User Fees Needed to Help FDA Manage its Full Plateabout 9 years ago
Viewpoint: Challenges and Opportunities for CDMOsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5